ImmunRise Biocontrol secured €5M from Baron Philippe de Rothschild and De Sangosse
02 July 2022
02 July 2022
Total investments received (USD): 5.09m
Round value (USD): 5.09m
Round investors:
De Sangosse
Baron Philippe de Rothschild
Company: ImmunRise Biocontrol
Related deals
Lys Therapeutics raised €5.5M from HTH VC, Bpifrance
Investments
15 November 2022
Javelot raised €10M from NextStage AM and IDIA Capital Investissement
Investments
27 September 2022
Micropep announced the completion of a €8.75 million Series A1 financing round led by Fall Line Capital.
Investments
28 June 2022
Interstellar Lab to raise a $5 million seed round with Urania Ventures, Auxxo, 7percent Ventures, Seldor Capital, E2MC, Kima Ventures and BPI.
Investments
06 March 2022
Lisaqua in a €4.9M funding deal backed by Litto Invest and Le Gouessant Agricultural Cooperative
Investments
25 February 2022
Belgium
Netherlands
Austria
Switzerland
Denmark
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
Sweden
Ireland
Portugal
Spain